CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma.

Hu, Jian Ming

CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma. [electronic resource] - Oncotarget Mar 2017 - 21526-21538 p. digital

Publication Type: Journal Article

1949-2553

10.18632/oncotarget.15630 doi


Adult
Aged
Antigens, CD--immunology
Antigens, Differentiation, Myelomonocytic--immunology
Asian People
Biomarkers, Tumor--metabolism
Carcinoma, Squamous Cell--immunology
Esophageal Neoplasms--immunology
Esophageal Squamous Cell Carcinoma
Female
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Macrophage Activation--immunology
Macrophages--immunology
Male
Matrix Metalloproteinase 9--metabolism
Middle Aged
Neovascularization, Pathologic--pathology
Prognosis
Proportional Hazards Models
Receptors, Cell Surface--immunology
Tumor Microenvironment--immunology
CD163 Antigen